HEPATOBILIARY MALIGNANCY - 09/09/11
Résumé |
The course of chronic cholestatic liver disease is frequently complicated by the development of hepatic tumors, which is best exemplified by the risk of cholangiocarcinoma in primary sclerosing cholangitis. The development of these malignancies often obviates the potential for transplantation and hastens the patient's clinical decline. Thus, it is important to discuss this complication of cholestatic liver disease. This article reviews the malignant potential of chronic cholestatic liver disease and its management in a variety of settings relevant to the hepatologist, radiologist, oncologist, and transplant surgeon.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to Gregory J. Gores, MD, Center for Basic Research in Digestive Diseases, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, gores.gregory@mayo.edu This work was supported by grants from the National Institutes of Health (DK 41876), the Gainey Foundation, St. Paul, Minnesota, and by the Mayo Foundation, Rochester, Minnesota |
Vol 2 - N° 2
P. 437-449 - mai 1998 Retour au numéro
Article précédent
- RECURRENCE OF PRIMARY BILIARY CIRRHOSIS, AUTOIMMUNE CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS AFTER LIVER TRANSPLANTATION
- Kenneth P. Batts, Xuedong Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?